 "Sohini Das")
Sohini Das
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das
Electric PV sales nearly double in September; e-two-wheeler sales rise 89%
EV penetration in passenger vehicles rises to 8.5 per cent as electric two-wheeler sales climb 88.7 per cent and established manufacturers capture more market growth.
 "Electric PV sales nearly double in September; e-two-wheeler sales rise 89%")
Auto dealers gear up for robust Oct as festival season bookings rise
Auto dealers expect deferred purchases to convert into festive deliveries from mid-October, while higher PV inventory and EV supply constraints remain key monitorables
 "Auto dealers gear up for robust Oct as festival season bookings rise")
Ayush eyes new frontiers: Insurance, hospitals may drive next growth phase
Insurance cover and hospitals could drive the next phase of expansion. But evidence-backed treatment will be key
 "Ayush eyes new frontiers: Insurance, hospitals may drive next growth phase")
GST Council may give export status to clinical trials for overseas sponsors
Proposals include ITC relief on free samples and expired drugs, while a 90% refund of accumulated credit could ease working-capital pressure for drugmakers
 "GST Council may give export status to clinical trials for overseas sponsors")
GST reforms agenda: Businesses likely to get wider motor vehicle ITC
Insurance, repairs and servicing may qualify; EVs could get matching tax treatment
 "GST reforms agenda: Businesses likely to get wider motor vehicle ITC")
Tata Sons boardgame likely to spur promoter relook at the charters
Experts say clearer boundaries between promoter oversight and professional management can help prevent governance conflicts
 "Tata Sons boardgame likely to spur promoter relook at the charters")
Novo eyes childhood obesity pilots in India, seeks wider public-sector role
Next-gen pipeline spans higher-dose, combination and oral therapies; company says it can meet India's demand for GLP-1 medicines as the market expands
 "Novo eyes childhood obesity pilots in India, seeks wider public-sector role")
CAFE-III norms locked, may make EVs cheaper but ICE vehicles costlier
Threefold sales weightage for battery EVs could encourage affordable models, while carmakers may price some higher-emission petrol and diesel vehicles higher to meet targets
 "CAFE-III norms locked, may make EVs cheaper but ICE vehicles costlier")
Range Rover Sport Electric bookings open in India, price due next year
The luxury SUV gets a 118.5 kWh battery, claimed WLTP range of up to 609 km and 550 PS output, and will be built at JLR's Solihull plant in the UK
 "Range Rover Sport Electric bookings open in India, price due next year")
Suzuki to halve vehicle development time by 2030, boost India capacity
Japanese automaker to improve raise manufacturing efficiency and expand India's role as a global production
 "Suzuki to halve vehicle development time by 2030, boost India capacity")
Entry-level sedans gain traction while midsized models continue to struggle
Entry sedans' PV share rose to 7.1% in Jan-Aug 2026, supported by CNG demand and lower ownership costs, while midsize sedans slipped to 0.9%
 "Entry-level sedans gain traction while midsized models continue to struggle")
Researchers explore immune-based approach for durable hair regrowth
A new review examines the potential of immune modulation and regenerative medicine for hair loss, but experts say no clinically validated 'hair vaccine' exists yet
 "Researchers explore immune-based approach for durable hair regrowth")
Netradyne, govt talk driver-monitoring systems for commercial vehicles
AI fleet-safety firm is testing its technology with Indian commercial vehicle makers for factory-level integration as it looks to expand beyond the US market
 "Netradyne, govt talk driver-monitoring systems for commercial vehicles")
Fuel shift gathers pace across vehicle segments as EV adoption rises
India's automobile market is seeing a steady shift in its fuel mix, with electric vehicles (EVs) gaining ground across passenger vehicles (PVs), two-wheelers, three-wheelers and commercial vehicles
 "Fuel shift gathers pace across vehicle segments as EV adoption rises")
JSW eyes 100,000-unit electric CV capacity by 2030 with AMPSTAR push
Rs 2,000-cr initial investment in AMPSTAR; group bets fleet economics, captive demand will drive e-truck adoption
 "JSW eyes 100,000-unit electric CV capacity by 2030 with AMPSTAR push")
EVs, CNG gain ground as India's automobile fuel mix steadily shifts
EVs gain ground across vehicle segments as petrol, diesel shares ease
 "EVs, CNG gain ground as India's automobile fuel mix steadily shifts")
One year of GST 2.0: Bharat shines, small car sales revive in auto sector
According to Fada, most of the revival happened in small-car sales due to better-performing rural markets
 "One year of GST 2.0: Bharat shines, small car sales revive in auto sector")
Top 10 pharma firms sustain volume growth as smaller rivals struggle
The top 10 in August included Sun Pharma, Cipla, Abbott, Mankind Pharma, Torrent Pharmaceuticals, Alkem Laboratories, Intas Pharmaceuticals, Lupin, Zydus Lifesciences and Dr Reddy's Laboratories
 "Top 10 pharma firms sustain volume growth as smaller rivals struggle")
Tata Trusts says Chandra reappointment invalid, invokes Mistry case
Tata Sons did not secure affirmative support of nominees: Tata Trusts
 "Tata Trusts says Chandra reappointment invalid, invokes Mistry case")
Takeda eyes 100 million annual dengue vaccine capacity with Bio E by 2029
Initial QDENGA doses for India to come from Germany; private-market launch planned in H1 2027
 "Takeda eyes 100 million annual dengue vaccine capacity with Bio E by 2029")